{
  "nctId": "NCT03676881",
  "briefTitle": "Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease",
  "officialTitle": "Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease",
  "protocolDocument": {
    "nctId": "NCT03676881",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2018-08-29",
    "uploadDate": "2018-09-17T11:41",
    "size": 1113575,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03676881/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 36,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2018-09-04",
    "completionDate": "2021-12",
    "primaryCompletionDate": "2021-12",
    "firstSubmitDate": "2018-09-04",
    "firstPostDate": "2018-09-19"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Age ≥ 60\n* Capable of giving consent, as stated by the University of California, San Diego Brief Assessment of Capacity to Consent (Appendix 9: UBACC)\n* Meeting the diagnostic criteria of MCI or CN (described below)\n* \\*\\*For MCI subjects: availability of a Study partner, defined as a person that knows the participant for at least 5 years, has frequent contact with them (≥2 days/week) and is knowledgeable of their functioning in activities of daily living\n\nExclusion Criteria:\n\n* Significant visual, hearing, or hand-motor impairment that may interfere with the CG testing sessions or Neuropsychological Assessment\n* Currently participating in Clinical Drug Trials\n* Currently participating in multiple observational studies (≥2)\n* Meeting the DSM-IV criteria for dementia at baseline\n* Color blindness\n* No consent to UBACC administration in MCI subjects\n* Non-fluent in English\n* Active Major depression, Stroke, Traumatic Brain Injury, substance abuse, any other neurological disease (with the exception of MCI in the MCI group).\n* For NCP project only:\n\nIn-ear hearing aid or cochlear implant, hearing device\n\n* Implanted pacemaker\n* Metal or plastic implants in skull\n* History of seizures\n* Allergy to rubbing alcohol or EEG gel\n* Unhealthy scalp (apparent open wounds and/or bruised or weakened skin)",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "60 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "CG scores (accuracy and reaction speed)",
        "description": "The standard scores are presented on a linear scale ranging between 0-150. This scale is broken down into three categories that reflect performance: Normal (90-150), Borderline (80-89), Abnormal (0-79).",
        "timeFrame": "Baseline visit during year 1"
      },
      {
        "measure": "MoCA scores",
        "description": "The total score is 30 points; a score of 26 or above is considered normal.",
        "timeFrame": "Baseline visit during year 1"
      },
      {
        "measure": "ERP´s amplitudes for Auditory sensation (N100)",
        "description": "mean and standard deviation in microvolt (μV).",
        "timeFrame": "Baseline visit during year 1"
      },
      {
        "measure": "ERP´s amplitude for Cognitive processing (N400)",
        "description": "mean and standard deviation in microvolt (μV)",
        "timeFrame": "Baseline visit during year 1"
      },
      {
        "measure": "ERP´s amplitude for Basic Attention (P300)",
        "description": "mean and standard deviation in microvolt (μV)",
        "timeFrame": "Baseline visit during year 1."
      },
      {
        "measure": "ERP´s latency for Auditory sensation (N100)",
        "description": "means and standard deviations in milliseconds (ms).",
        "timeFrame": "Baseline visit during year 1."
      },
      {
        "measure": "ERP´s latency for Cognitive processing (N400)",
        "description": "means and standard deviations in milliseconds (ms).",
        "timeFrame": "Baseline visit during year 1."
      },
      {
        "measure": "ERP´s latency for Basic Attention (P300)",
        "description": "means and standard deviations in milliseconds (ms).",
        "timeFrame": "Baseline visit during year 1."
      },
      {
        "measure": "Longitudinal changes in CG scores",
        "description": "The standard scores are presented on a linear scale ranging between 0-150. This scale is broken down into three categories that reflect performance: Normal (90-150), Borderline (80-89), Abnormal (0-79). Scores over the three year period will be compared.",
        "timeFrame": "Complete 3 year period"
      },
      {
        "measure": "Longitudinal changes in MoCA scores",
        "description": "The total score is 30 points; a score of 26 or above is considered normal. Scores over the three year period will be compared.",
        "timeFrame": "Complete 3 year period"
      },
      {
        "measure": "Longitudinal change in Mini-mental state examination (MMSE)",
        "description": "Change is being assessed. MMSE - any score greater than or equal to 24 points (out of 30) indicates a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10-18 points) or mild (19-23 points) cognitive impairment.",
        "timeFrame": "baseline, 12 months, 24 months, and 36 months follow ups"
      },
      {
        "measure": "Longitudinal change in FAQ",
        "description": "Change is being assessed. Sum scores (range 0-30). Cutpoint of 9 (dependent in 3 or more activities) is recommended to indicate impaired function and possible cognitive impairment.",
        "timeFrame": "baseline 12 months, 24 months, and 36 months follow ups"
      },
      {
        "measure": "Longitudinal change in GPCOG scores",
        "description": "Change is being assessed. A scale for rating the perceived impact of the cognitive difficulties in daily life functions. Ratings go from 0 (no interference) to 4 (extreme interference).",
        "timeFrame": "baseline 12 months, 24 months, and 36 months follow ups"
      },
      {
        "measure": "Longitudinal change in Rey-Osterrieth Complex Figure test (RCFT)",
        "description": "Change is being assessed (copy, immediate and delayed recall). RCFT : scoring drawings based on the widely used 36-point scoring system. The same scoring criteria apply to all three drawing trials. Each of the 18 scoring units is scored based on accuracy and placement criteria. Unit scores range from two (accurately drawn, correctly placed) to zero (inaccurately drawn, incorrectly placed, unrecognizable, omitted).",
        "timeFrame": "baseline, 12 months, 24 months, and 36 months follow ups"
      },
      {
        "measure": "Longitudinal change in Hopkins Verbal Learning test (HVLT-R)",
        "description": "Change is being assessed. HVLT-R : Raw scores are derived for Total score is the total correct recall of the 3 learning trials (3 trials, 12 items, max score = /36) (0-36), Delayed Recall is out of 12 (max 12) (0-12), Retention (percent retained) is the total recalled at delay (max 12) divided by the best score on trial 2 or 3. Score range is 0% or better. Recognition Discrimination Index is the number of hits minus the number of false positive identifications. Max score is 12 (ie 12 hits, no intrusions).",
        "timeFrame": "baseline, 12 months, 24 months, and 36 months follow ups"
      },
      {
        "measure": "Longitudinal change in Trail Making Tests A and B",
        "description": "Change is being assessed.Trail making A \\& B average time is 29 \\& 75 seconds, \\>78 \\& \\>273 seconds considered deficient, respectively.",
        "timeFrame": "baseline, 12 months, 24 months, and 36 months follow ups"
      },
      {
        "measure": "Longitudinal change in Semantic Verbal Fluency test (animals).",
        "description": "Change is being assessed. Semantic verbal fluency on animals based on most productive number of animals named in 60 seconds.",
        "timeFrame": "baseline, 12 months, 24 months, and 36 months follow ups"
      },
      {
        "measure": "Longitudinal change in ERP´s amplitudes for Auditory sensation (N100)",
        "description": "Change is being assessed. Means and standard deviations in microvolt (μV).",
        "timeFrame": "baseline, 6 months, 12 months, 24 months, and 36 months follow ups."
      },
      {
        "measure": "Longitudinal change in ERP´s amplitudes for Cognitive processing (N400)",
        "description": "Change is being assessed. Means and standard deviations in microvolt (μV).",
        "timeFrame": "baseline, 6 months, 12 months, 24 months, and 36 months follow ups.]"
      },
      {
        "measure": "Longitudinal change in ERP´s amplitudes for Basic Attention (P300)",
        "description": "Change is being assessed. Means and standard deviations in microvolt (μV).",
        "timeFrame": "baseline, 6 months, 12 months, 24 months, and 36 months follow ups.]"
      },
      {
        "measure": "Longitudinal change in ERP´s latencies for Auditory sensation (N100)",
        "description": "Change is being assessed. Means and standard deviations in milliseconds (ms).",
        "timeFrame": "baseline, 6 months, 12 months, 24 months, and 36 months follow ups"
      },
      {
        "measure": "Longitudinal change in ERP´s latencies for Cognitive processing (N400)",
        "description": "Change is being assessed. Means and standard deviations in milliseconds (ms).",
        "timeFrame": "baseline, 6 months, 12 months, 24 months, and 36 months follow ups"
      },
      {
        "measure": "Longitudinal change in ERP´s latencies for Basic Attention (P300)",
        "description": "Change is being assessed. Means and standard deviations in milliseconds (ms).",
        "timeFrame": "baseline, 6 months, 12 months, 24 months, and 36 months follow ups"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 23,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 23
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:40.012Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}